Arthroscopy (also called arthroscopic surgery) is a minimally invasive surgical procedure in which an examination and sometimes treatment of damage of the interior of a joint is performed using an arthroscope, a type of endoscope that is inserted into the joint through a small incision. Arthroscopic procedures can be performed either to evaluate or to treat many orthopaedic conditions including torn floating cartilage, torn surface cartilage, ACL reconstruction, and trimming damaged cartilage.
Arthroscopic treatment of a common hip problem that leads to arthritis is successful in terms of restoring range of motion, according to results from a recent Hospital for Special Surgery study.
A history of cancer was a significant risk factor for developing blood clotting issues following knee arthroscopy, according to a study being presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. Researchers from the Mayo Clinic in Rochester, Minnesota analyzed the records of more than 12,000 patients who had undergone the common knee procedure.
Using a combination of hypnosis and local anaesthesia (LA) for certain types of surgery can aid the healing process and reduce drug use and time spent in hospital, anaesthesiologists have found. The combination could also help avoid cancer recurrence and metastases, according to new research to be presented today at the European Anaesthesiology Congress in Amsterdam.
Omeros Corporation today announced that it is advancing two of its product candidates from its PharmacoSurgery platform – OMS103HP for arthroscopic meniscectomy and OMS302 for intra-ocular lens replacement surgery – into Phase 3 clinical development programs.
Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced first quarter 2011 financial results for the period ended April 2, 2011.
With spring here and summer on the way, children are back on the field and ready to score one for the team. Unfortunately, this also means more opportunities for injury, from simple twisted ankles to serious concussions.
Biomet, Inc., a global leader in the manufacture of orthopedic and biotechnology products, today announced clearance of its Active Articulation E1 Dual Mobility Hip System, by the United States Food and Drug Administration.
Biomet, Inc. announced today financial results for its third fiscal quarter ended February 28, 2011.
According to Millennium Research Group, the global authority on medical technology market intelligence, growth standouts in European surgical procedures over the next five years will be in percutaneous heart valve procedures, arthroscopy and single-port laparoscopy.
OXINIUM Oxidized Zirconium, the patented advanced bearing material from Smith & Nephew Orthopaedics Division, has been awarded a C1 premium reimbursement classification in Japan for use in hip replacement surgery.
Patients who undergo elective orthopedic surgeries at high-volume, regional hospitals have better surgical outcomes and experience fewer complications than those who undergo those surgeries at local hospitals, according to research being presented by Hospital for Special Surgery investigators at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.
A new study has identified factors that predict the ability of a professional dancer to return to professional performance after hip arthroscopy surgery. The study by Hospital for Special Surgery investigators will be presented at the American Academy of Orthopaedic Surgeons annual meeting, held Feb. 15-19 in San Diego, Calif.
Until now, the risk of pulmonary embolism after a knee arthroscopy has not been accurately defined and risk factors have only been suggested but not proven. New research, presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons shows that the incidence of symptomatic PE after outpatient knee arthroscopy is .028 percent.
At this week's annual meeting of the American Academy of Orthopedic Surgeons, Smith & Nephew Orthopaedic Division introduced its Short Modular Femoral Hip System, a modular total hip replacement stem system that exceeds the versatility and neck strength of a standard, full-size primary hip stem, while providing the stability of the traditionally longer, more invasive implant.
Biomet, and the Orthopaedic Research and Education Foundation announced today Biomet's 2011 donation of $1.3 million for funding graduate medical education programs in orthopaedic surgery.
New research found clinicians who care for patients with osteoarthritis are likely not following standard care guidelines that are based on current medical evidence.
New research found clinicians who care for patients with osteoarthritis (OA) are likely not following standard care guidelines that are based on current medical evidence. Researchers noted physicians were prescribing medications for pain and inflammation, or opting for surgical interventions rather than recommending weight loss plans or exercise programs to OA patients.
Biomet, Inc., a global leader in the manufacture of orthopedic and biotechnology products, announced today that its subsidiary, Biomet Biologics, LLC, has completed the required 230 subject enrollment for its Recover® Kit clinical trial. This clinical trial studies the use of the Recover® Kit device, which produces autologous platelet-rich plasma (PRP) to treat chronic tennis elbow (lateral epicondylitis).
A newly released patient registry reports that hip replacement implants made from ceramicized metal heads which articulate against polyethylene lined cups have been shown to have superior survivorship compared to implants made from any other material five years after surgery.
Arrowhead Research Corporation today announced that its portfolio company, Nanotope, Inc., has entered into an agreement with Smith & Nephew, Inc., a member of the Smith & Nephew plc group to develop a cartilage regeneration product for human healthcare markets using a subset of its proprietary regenerative medicine technology.